Insider Transactions in Q2 2022 at Invitae Corp (NVTA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 19
2022
|
Robert F. Werner Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,746
-1.34%
|
$8,238
$3.4 P/Share
|
|
May 17
2022
|
Robert L Nussbaum Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,098
-1.49%
|
$18,294
$3.81 P/Share
|
|
May 17
2022
|
Yafei Wen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,042
-4.72%
|
$51,126
$3.81 P/Share
|
|
May 17
2022
|
Sean E George Director |
SELL
Open market or private sale
|
Direct |
18,296
-2.25%
|
$54,888
$3.81 P/Share
|
|
May 17
2022
|
Thomas Brida |
SELL
Open market or private sale
|
Direct |
6,098
-1.53%
|
$18,294
$3.81 P/Share
|
|
May 17
2022
|
Kenneth D. Knight Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
28,295
-5.17%
|
$84,885
$3.81 P/Share
|
|
May 17
2022
|
Robert F. Werner Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,356
-3.47%
|
$22,068
$3.81 P/Share
|
|
Apr 28
2022
|
Kimber D Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,100
+44.15%
|
-
|
|
Apr 28
2022
|
Geoffrey Crouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,100
+34.91%
|
-
|
|
Apr 28
2022
|
Christine Marie Gorjanc Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,100
+44.15%
|
-
|
|
Apr 28
2022
|
Chitra Nayak Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,100
+44.15%
|
-
|
|
Apr 28
2022
|
Eric Aguiar Director |
BUY
Grant, award, or other acquisition
|
Direct |
43,400
+29.74%
|
-
|
|
Apr 09
2022
|
Kenneth D. Knight Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
225,000
+29.14%
|
-
|
|
Apr 09
2022
|
Robert F. Werner Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
135,815
+39.3%
|
-
|
|
Apr 09
2022
|
Thomas Brida |
BUY
Grant, award, or other acquisition
|
Direct |
168,511
+29.73%
|
-
|
|
Apr 09
2022
|
Robert L Nussbaum Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
168,511
+29.14%
|
-
|
|
Apr 09
2022
|
Yafei Wen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
225,000
+38.37%
|
-
|